Birdwatch Archive

Birdwatch Note

2024-10-19 04:29:58 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

あたかもコスタイベ(レプリコンワクチン)が世界中で開発中止、申請取下、承認却下等が行われたかのような言説ですが、そのような事実はありません(p.6,53) https://www.mhlw.go.jp/content/10601000/001305553.pdf 著者は匿名なので本当に社員かどうか不明です。 書籍名に「販売を命じられた」とあり、少なくとも開発担当ではないことが明らかです。 前書きに非公開情報や企業の内部情報はないと明言されています https://www.amazon.co.jp/dp/B0DHCYPZJ2?asin=B0DHCYPZJ2&revisionId=e84ae297&format=3&depth=1 コスタイベの安全性と有効性は治験で良好と評価されています https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001316061.pdf https://www.pmda.go.jp/drugs/2024/P20240917001/780009000_30500AMX00282_A100_1.pdf https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#20 IF値の高い医学誌・科学誌の査読済論文、WHOや先進国民主主義の政府機関の公式発表等の原典を参照しましょう https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#34 https://togetter.com/li/2416068 https://togetter.com/li/2131189 https://togetter.com/li/2174198

Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1847388974647746751

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1847495381703413806
  • noteId - 1847495381703413806
  • participantId -
  • noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
  • createdAtMillis - 1729312198459
  • tweetId - 1847388974647746751
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • あたかもコスタイベ(レプリコンワクチン)が世界中で開発中止、申請取下、承認却下等が行われたかのような言説ですが、そのような事実はありません(p.6,53) https://www.mhlw.go.jp/content/10601000/001305553.pdf 著者は匿名なので本当に社員かどうか不明です。 書籍名に「販売を命じられた」とあり、少なくとも開発担当ではないことが明らかです。 前書きに非公開情報や企業の内部情報はないと明言されています https://www.amazon.co.jp/dp/B0DHCYPZJ2?asin=B0DHCYPZJ2&revisionId=e84ae297&format=3&depth=1 コスタイベの安全性と有効性は治験で良好と評価されています https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001316061.pdf https://www.pmda.go.jp/drugs/2024/P20240917001/780009000_30500AMX00282_A100_1.pdf https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#20 IF値の高い医学誌・科学誌の査読済論文、WHOや先進国民主主義の政府機関の公式発表等の原典を参照しましょう https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#34 https://togetter.com/li/2416068 https://togetter.com/li/2131189 https://togetter.com/li/2174198

Note Ratings

rated at rated by
2024-10-21 03:07:50 -0500 Rating Details
2024-10-20 22:30:39 -0500 Rating Details
2024-10-19 18:48:33 -0500 Rating Details
2024-10-19 16:22:33 -0500 Rating Details
2024-10-19 16:04:16 -0500 Rating Details
2024-10-19 08:12:25 -0500 Rating Details
2024-10-19 07:55:58 -0500 Rating Details
2024-10-19 07:48:38 -0500 Rating Details
2024-10-19 07:36:01 -0500 Rating Details
2024-10-19 07:35:22 -0500 Rating Details
2024-10-19 07:32:21 -0500 Rating Details
2024-10-19 07:32:20 -0500 Rating Details
2024-10-19 07:31:07 -0500 Rating Details
2024-10-19 07:31:00 -0500 Rating Details
2024-10-19 07:24:28 -0500 Rating Details
2024-10-19 06:54:22 -0500 Rating Details
2024-10-19 06:39:10 -0500 Rating Details
2024-10-19 06:36:46 -0500 Rating Details
2024-10-19 06:36:16 -0500 Rating Details
2024-10-19 06:34:48 -0500 Rating Details
2024-10-19 06:12:38 -0500 Rating Details
2024-10-19 05:46:05 -0500 Rating Details
2024-10-19 05:31:07 -0500 Rating Details
2024-10-19 05:17:01 -0500 Rating Details
2024-10-19 05:16:57 -0500 Rating Details
2024-10-19 04:20:38 -0500 Rating Details
2024-10-19 03:24:22 -0500 Rating Details
2024-10-19 02:36:47 -0500 Rating Details
2024-10-19 02:32:56 -0500 Rating Details
2024-10-19 02:12:37 -0500 Rating Details
2024-10-19 01:32:10 -0500 Rating Details
2024-10-19 00:58:42 -0500 Rating Details
2024-10-19 00:52:41 -0500 Rating Details
2024-10-19 00:21:21 -0500 Rating Details
2024-10-19 00:05:44 -0500 Rating Details
2024-10-19 00:03:31 -0500 Rating Details
2024-10-19 00:02:04 -0500 Rating Details
2024-10-18 23:58:52 -0500 Rating Details
2024-10-18 23:56:44 -0500 Rating Details
2024-10-18 23:54:01 -0500 Rating Details
2024-10-18 23:49:47 -0500 Rating Details
2024-10-18 23:41:44 -0500 Rating Details
2024-10-18 23:33:24 -0500 Rating Details
2024-10-25 14:04:45 -0500 Rating Details
2024-10-23 16:47:46 -0500 Rating Details
2024-10-20 01:56:23 -0500 Rating Details
2024-10-20 00:05:45 -0500 Rating Details
2024-10-19 16:35:57 -0500 Rating Details
2024-10-19 09:24:10 -0500 Rating Details
2024-10-19 09:03:25 -0500 Rating Details
2024-10-19 07:43:49 -0500 Rating Details
2024-10-19 07:35:55 -0500 Rating Details
2024-10-19 07:06:33 -0500 Rating Details
2024-10-19 06:48:46 -0500 Rating Details
2024-10-19 06:47:25 -0500 Rating Details
2024-10-19 06:40:39 -0500 Rating Details
2024-10-19 06:35:16 -0500 Rating Details
2024-10-19 06:35:09 -0500 Rating Details
2024-10-19 06:29:53 -0500 Rating Details
2024-10-19 06:16:10 -0500 Rating Details
2024-10-19 05:28:09 -0500 Rating Details
2024-10-19 04:18:37 -0500 Rating Details
2024-10-19 04:08:11 -0500 Rating Details
2024-10-19 03:34:02 -0500 Rating Details
2024-10-19 03:01:30 -0500 Rating Details
2024-10-19 02:10:14 -0500 Rating Details
2024-10-19 00:41:34 -0500 Rating Details
2024-10-19 00:19:24 -0500 Rating Details
2024-10-19 00:19:07 -0500 Rating Details
2024-10-19 00:13:36 -0500 Rating Details
2024-10-19 00:07:49 -0500 Rating Details
2024-10-18 23:59:07 -0500 Rating Details
2024-10-18 23:55:32 -0500 Rating Details
2024-10-18 23:47:17 -0500 Rating Details
2024-10-18 23:44:31 -0500 Rating Details
2024-10-21 20:43:16 -0500 Rating Details
2024-10-21 03:41:32 -0500 Rating Details
2024-10-21 00:11:31 -0500 Rating Details
2024-10-20 21:07:39 -0500 Rating Details
2024-10-20 20:59:22 -0500 Rating Details
2024-10-20 17:50:48 -0500 Rating Details
2024-10-20 05:00:39 -0500 Rating Details
2024-10-19 08:11:39 -0500 Rating Details
2024-10-19 07:39:01 -0500 Rating Details
2024-10-19 07:28:21 -0500 Rating Details
2024-10-19 07:19:59 -0500 Rating Details
2024-10-19 07:11:22 -0500 Rating Details
2024-10-19 07:01:50 -0500 Rating Details
2024-10-19 06:53:27 -0500 Rating Details
2024-10-19 06:51:15 -0500 Rating Details
2024-10-19 06:42:27 -0500 Rating Details
2024-10-19 05:22:23 -0500 Rating Details
2024-10-19 05:20:57 -0500 Rating Details
2024-10-19 04:35:53 -0500 Rating Details
2024-10-19 03:48:43 -0500 Rating Details
2024-10-19 02:30:08 -0500 Rating Details
2024-10-19 02:07:42 -0500 Rating Details
2024-10-19 01:47:17 -0500 Rating Details
2024-10-19 01:25:55 -0500 Rating Details
2024-10-19 01:19:17 -0500 Rating Details
2024-10-19 01:17:20 -0500 Rating Details
2024-10-19 01:09:55 -0500 Rating Details
2024-10-19 01:00:00 -0500 Rating Details
2024-10-19 00:48:28 -0500 Rating Details
2024-10-19 00:27:18 -0500 Rating Details
2024-10-19 00:13:32 -0500 Rating Details
2024-10-19 00:10:45 -0500 Rating Details
2024-10-19 00:03:27 -0500 Rating Details
2024-10-19 00:00:03 -0500 Rating Details
2024-10-18 23:53:40 -0500 Rating Details
2024-10-18 23:52:03 -0500 Rating Details
2024-10-18 23:45:07 -0500 Rating Details
2024-10-18 23:42:59 -0500 Rating Details